Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:20837020rdf:typepubmed:Citationlld:pubmed
pubmed-article:20837020lifeskim:mentionsumls-concept:C0027651lld:lifeskim
pubmed-article:20837020lifeskim:mentionsumls-concept:C0023621lld:lifeskim
pubmed-article:20837020lifeskim:mentionsumls-concept:C0086418lld:lifeskim
pubmed-article:20837020lifeskim:mentionsumls-concept:C1801960lld:lifeskim
pubmed-article:20837020lifeskim:mentionsumls-concept:C1327616lld:lifeskim
pubmed-article:20837020lifeskim:mentionsumls-concept:C0003241lld:lifeskim
pubmed-article:20837020lifeskim:mentionsumls-concept:C0005516lld:lifeskim
pubmed-article:20837020lifeskim:mentionsumls-concept:C0204727lld:lifeskim
pubmed-article:20837020lifeskim:mentionsumls-concept:C0205409lld:lifeskim
pubmed-article:20837020lifeskim:mentionsumls-concept:C1540291lld:lifeskim
pubmed-article:20837020lifeskim:mentionsumls-concept:C1710360lld:lifeskim
pubmed-article:20837020lifeskim:mentionsumls-concept:C0439831lld:lifeskim
pubmed-article:20837020lifeskim:mentionsumls-concept:C1709450lld:lifeskim
pubmed-article:20837020pubmed:issue2lld:pubmed
pubmed-article:20837020pubmed:dateCreated2010-12-17lld:pubmed
pubmed-article:20837020pubmed:abstractTextEndosialin/TEM1 is predominantly expressed on neovasculature, thus ideally suited for diagnostic, targeted imaging and therapy of cancer. To isolate TEM1-specific affinity reagents, we thought to screen a recombinant antibody (scFv) library derived from the repertoire of a patient with thrombotic thrombocytopenic purpura (TTP), as autoimmune disorders may produce self-reactive specificities. The yeast-display scFv library was constructed by homologous recombination of the TTP patient repertoire originally expressed on M13 bacteriophage in the novel vector pAGA2 for yeast-display expression. The TTP yeast-display library (10? members) was screened by magnetic and flow sorting with human TEM1 recombinant protein. A pool of yeast-display scFv able to detect 2nM of TEM1 was obtained and transformed into yeast-secreted scFv by homologous recombination using the novel p416 BCCP vector for yeast secretion of biotinylated scFv. Anti-TEM1 yeast-secreted scFv were independently validated in vitro by flow cytometry analysis and ELISA assays, then in vivo biotinylated in N-termini to produce biobodies. Biobody-78 bound specifically to Endosialin/TEM1-expressing ovarian tumor in vivo, with functional stability over 48 h. Our results suggest that our novel paired display-secretory yeast libraries can serve as an ideal platform for the rapid isolation of high-affinity reagents, and that anti-TEM1 biobody-78 can be used for in vitro assays including flow cytometry analysis, as well as in vivo for targeted imaging and therapy of cancer.lld:pubmed
pubmed-article:20837020pubmed:granthttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:20837020pubmed:granthttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:20837020pubmed:granthttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:20837020pubmed:granthttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:20837020pubmed:granthttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:20837020pubmed:languageenglld:pubmed
pubmed-article:20837020pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:20837020pubmed:citationSubsetIMlld:pubmed
pubmed-article:20837020pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:20837020pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:20837020pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:20837020pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:20837020pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:20837020pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:20837020pubmed:statusMEDLINElld:pubmed
pubmed-article:20837020pubmed:monthJanlld:pubmed
pubmed-article:20837020pubmed:issn1872-7905lld:pubmed
pubmed-article:20837020pubmed:authorpubmed-author:SchollerNatha...lld:pubmed
pubmed-article:20837020pubmed:authorpubmed-author:CoukosGeorgeGlld:pubmed
pubmed-article:20837020pubmed:authorpubmed-author:SiegelDon LDLlld:pubmed
pubmed-article:20837020pubmed:authorpubmed-author:LiChunshengClld:pubmed
pubmed-article:20837020pubmed:authorpubmed-author:ZhaoAizhiAlld:pubmed
pubmed-article:20837020pubmed:authorpubmed-author:Nunez-CruzSel...lld:pubmed
pubmed-article:20837020pubmed:copyrightInfoCopyright © 2010 Elsevier B.V. All rights reserved.lld:pubmed
pubmed-article:20837020pubmed:issnTypeElectroniclld:pubmed
pubmed-article:20837020pubmed:day5lld:pubmed
pubmed-article:20837020pubmed:volume363lld:pubmed
pubmed-article:20837020pubmed:ownerNLMlld:pubmed
pubmed-article:20837020pubmed:authorsCompleteYlld:pubmed
pubmed-article:20837020pubmed:pagination221-32lld:pubmed
pubmed-article:20837020pubmed:dateRevised2011-10-5lld:pubmed
pubmed-article:20837020pubmed:meshHeadingpubmed-meshheading:20837020...lld:pubmed
pubmed-article:20837020pubmed:meshHeadingpubmed-meshheading:20837020...lld:pubmed
pubmed-article:20837020pubmed:meshHeadingpubmed-meshheading:20837020...lld:pubmed
pubmed-article:20837020pubmed:meshHeadingpubmed-meshheading:20837020...lld:pubmed
pubmed-article:20837020pubmed:meshHeadingpubmed-meshheading:20837020...lld:pubmed
pubmed-article:20837020pubmed:meshHeadingpubmed-meshheading:20837020...lld:pubmed
pubmed-article:20837020pubmed:meshHeadingpubmed-meshheading:20837020...lld:pubmed
pubmed-article:20837020pubmed:meshHeadingpubmed-meshheading:20837020...lld:pubmed
pubmed-article:20837020pubmed:meshHeadingpubmed-meshheading:20837020...lld:pubmed
pubmed-article:20837020pubmed:meshHeadingpubmed-meshheading:20837020...lld:pubmed
pubmed-article:20837020pubmed:meshHeadingpubmed-meshheading:20837020...lld:pubmed
pubmed-article:20837020pubmed:meshHeadingpubmed-meshheading:20837020...lld:pubmed
pubmed-article:20837020pubmed:meshHeadingpubmed-meshheading:20837020...lld:pubmed
pubmed-article:20837020pubmed:meshHeadingpubmed-meshheading:20837020...lld:pubmed
pubmed-article:20837020pubmed:meshHeadingpubmed-meshheading:20837020...lld:pubmed
pubmed-article:20837020pubmed:meshHeadingpubmed-meshheading:20837020...lld:pubmed
pubmed-article:20837020pubmed:meshHeadingpubmed-meshheading:20837020...lld:pubmed
pubmed-article:20837020pubmed:year2011lld:pubmed
pubmed-article:20837020pubmed:articleTitleRapid isolation of high-affinity human antibodies against the tumor vascular marker Endosialin/TEM1, using a paired yeast-display/secretory scFv library platform.lld:pubmed
pubmed-article:20837020pubmed:affiliationPenn Ovarian Cancer Research Center, Center for Research on Reproduction and Women's Health (CRRWH), Department of Obstetrics and Gynecology, University of Pennsylvania, Philadelphia, PA 19104, USA.lld:pubmed
pubmed-article:20837020pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:20837020pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed
pubmed-article:20837020pubmed:publicationTypeResearch Support, N.I.H., Extramurallld:pubmed